6-116279302-TCAC-TCACCAC
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBA1
The NM_003309.4(TSPYL1):c.526_528dupGTG(p.Val176dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 1,609,234 control chromosomes in the GnomAD database, including 386,893 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.76 ( 45285 hom., cov: 0)
Exomes 𝑓: 0.68 ( 341608 hom. )
Consequence
TSPYL1
NM_003309.4 conservative_inframe_insertion
NM_003309.4 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.225
Publications
5 publications found
Genes affected
TSPYL1 (HGNC:12382): (TSPY like 1) The protein encoded by this gene is found in the nucleolus and is similar to that of a family of genes on the Y-chromosome. This gene is intronless. Defects in this gene are a cause of sudden infant death with dysgenesis of the testes syndrome (SIDDT). [provided by RefSeq, Dec 2009]
DSE (HGNC:21144): (dermatan sulfate epimerase) The protein encoded by this gene is a tumor-rejection antigen. It is localized to the endoplasmic reticulum and functions to convert D-glucuronic acid to L-iduronic acid during the biosynthesis of dermatan sulfate. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. Mutations in this gene cause inmusculocontractural Ehlers-Danlos syndrome. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 9, and a paralogous gene exists on chromosome 18. [provided by RefSeq, Apr 2016]
DSE Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndrome, musculocontractural type 2Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- Ehlers-Danlos syndrome, musculocontractural typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_003309.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 6-116279302-T-TCAC is Benign according to our data. Variant chr6-116279302-T-TCAC is described in ClinVar as Benign. ClinVar VariationId is 1301648.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.973 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TSPYL1 | NM_003309.4 | c.526_528dupGTG | p.Val176dup | conservative_inframe_insertion | Exon 1 of 1 | ENST00000368608.4 | NP_003300.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSPYL1 | ENST00000368608.4 | c.526_528dupGTG | p.Val176dup | conservative_inframe_insertion | Exon 1 of 1 | 6 | NM_003309.4 | ENSP00000357597.4 |
Frequencies
GnomAD3 genomes AF: 0.761 AC: 115322AN: 151600Hom.: 45227 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
115322
AN:
151600
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.676 AC: 985557AN: 1457516Hom.: 341608 Cov.: 79 AF XY: 0.682 AC XY: 494778AN XY: 725246 show subpopulations
GnomAD4 exome
AF:
AC:
985557
AN:
1457516
Hom.:
Cov.:
79
AF XY:
AC XY:
494778
AN XY:
725246
show subpopulations
African (AFR)
AF:
AC:
31176
AN:
33476
American (AMR)
AF:
AC:
36923
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
17832
AN:
26136
East Asian (EAS)
AF:
AC:
39649
AN:
39700
South Asian (SAS)
AF:
AC:
78799
AN:
86258
European-Finnish (FIN)
AF:
AC:
37225
AN:
49142
Middle Eastern (MID)
AF:
AC:
4241
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
697611
AN:
1111944
Other (OTH)
AF:
AC:
42101
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
22013
44025
66038
88050
110063
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18764
37528
56292
75056
93820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.761 AC: 115440AN: 151718Hom.: 45285 Cov.: 0 AF XY: 0.771 AC XY: 57141AN XY: 74122 show subpopulations
GnomAD4 genome
AF:
AC:
115440
AN:
151718
Hom.:
Cov.:
0
AF XY:
AC XY:
57141
AN XY:
74122
show subpopulations
African (AFR)
AF:
AC:
38176
AN:
41396
American (AMR)
AF:
AC:
11639
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2418
AN:
3472
East Asian (EAS)
AF:
AC:
5115
AN:
5134
South Asian (SAS)
AF:
AC:
4462
AN:
4796
European-Finnish (FIN)
AF:
AC:
7981
AN:
10492
Middle Eastern (MID)
AF:
AC:
195
AN:
290
European-Non Finnish (NFE)
AF:
AC:
43343
AN:
67864
Other (OTH)
AF:
AC:
1524
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1271
2542
3813
5084
6355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
3296
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, musculocontractural type 2 Benign:1
Apr 02, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.